- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Janssen Pharmaceutical K.K.
Total 441 results
-
Janssen Pharmaceutica N.V., BelgiumCompletedArthritis | Osteoarthritis | Rheumatoid Arthritis
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Duke UniversityJanssen PharmaceuticalsCompletedProstate CancerUnited States
-
Columbia UniversityJanssen PharmaceuticalsRecruitingRecurrent Prostate CancerUnited States
-
Pharmacyclics LLC.Janssen PharmaceuticalsCompletedMantle Cell LymphomaUnited States, United Kingdom, Germany, Poland
-
Duke UniversityJanssen PharmaceuticalsCompleted
-
PETHEMA FoundationJanssen PharmaceuticaRecruitingHigh-Risk de Novo Multiple MyelomaSpain
-
Janssen Pharmaceutica N.V., BelgiumRecruitingProstatic NeoplasmsItaly, Russian Federation, Brazil, Portugal, Belgium, Spain, United States, Austria, Hungary, Turkey, Germany, Australia, Poland, Mexico, Finland, Slovakia, Lebanon, Czechia, Denmark, Jordan, Sweden
-
Janssen Pharmaceutica N.V., BelgiumActive, not recruitingBipolar DisorderUnited States, Spain, Poland, Canada
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumTerminated
-
Janssen Pharmaceutica N.V., BelgiumCompletedProstate CancerFrance, Poland, United Kingdom, Belgium, Germany, Spain, Israel, Portugal, Slovenia, Turkey, Sweden, Austria, Russian Federation, Luxembourg, Switzerland
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedProstate CancerUnited Kingdom, Belgium, Hungary, Germany
-
Janssen Pharmaceutica N.V., BelgiumCompletedHepatitis, ChronicFrance, United Kingdom, Belgium, Germany, Netherlands, Switzerland
-
Janssen Pharmaceutica N.V., BelgiumCompletedRespiratory Tract Infections | Influenza, Human | Respiratory Syncytial Virus InfectionsUnited States
-
Janssen Pharmaceutica N.V., BelgiumCompletedMultiple MyelomaFrance, Poland, Ukraine, Germany, Spain, Israel, Portugal, Slovenia, South Africa, Turkey, Greece, Estonia, Russian Federation, Hungary, Austria, Lithuania, Macedonia, The Former Yugoslav Republic of, Latvia, Croatia, Denmark, A...
-
Janssen Pharmaceutica N.V., BelgiumCompletedSchizophreniaTurkey, Russian Federation, Croatia
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedMajor Depressive DisorderBelgium
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder
-
Janssen Pharmaceutica N.V., BelgiumCompletedConduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
-
Janssen Pharmaceutica N.V., BelgiumCompletedPsychotic Disorders | Schizophrenia | Emergency Treatment
-
Janssen Pharmaceutica N.V., BelgiumCompletedGastroesophageal Reflux | Heartburn
-
Janssen Pharmaceutica N.V., BelgiumWithdrawnHepatitis B, ChronicGermany, France, Italy, Spain, Denmark, Portugal, Greece
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedPsoriatic ArthritisFrance, United Kingdom, Belgium, Spain, Netherlands, Greece, Russian Federation
-
Janssen Pharmaceutica N.V., BelgiumTerminated
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedPainFrance, Poland, Germany, Slovenia, Sweden, Czech Republic, Norway, Slovakia, Switzerland, Denmark
-
Janssen Pharmaceutica N.V., BelgiumCompletedBipolar DisorderChina, Taiwan, Colombia, India, Malaysia, Russian Federation, South Africa, Greece, Peru, Germany, Mexico, Lebanon, Indonesia, Philippines, Jordan
-
Janssen Pharmaceutica N.V., BelgiumCompletedSchizophreniaUnited Kingdom, Slovenia, Denmark, Finland, France, Greece, Israel, Norway, Sweden, Switzerland
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedMental Disorders | Brain Diseases | Nervous System Diseases | Dementia | Alzheimer Disease
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedPsychotic Disorders | Schizophrenia
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedAttention Deficit Disorder With Hyperactivity
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedDementia | Alzheimer Disease | Dementia, Vascular
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedNeoplasms | LymphomaUnited Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Primus PharmaceuticalsKGK Science Inc.Not yet recruitingScleroderma, Systemic | Digital Ulcer
-
International CTEPH AssociationJanssen PharmaceuticalsRecruitingChronic Thromboembolic Pulmonary Hypertension | CTEPHUnited States, Denmark, Belgium, Canada, Japan, Argentina, Italy, Austria, Poland, India, Spain, Mexico, United Kingdom, China, Brazil, Turkey, Germany, Singapore, Colombia
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsCompletedHIV InfectionsGermany, Taiwan, France, United States, Canada, Belgium, Australia, Netherlands, Spain, United Kingdom, Italy, Argentina, Russian Federation